Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Howlander N, Noone AM, Krapcho M et al (2014) SEER cancer statistics review 1975-2012. National Cancer Institute, Bethesda
2. Yurdakul AS, Kocatürk C, Bayiz H, Gürsoy S, Bircan A, Özcan A, Akkoçlu A, Uluorman F, Çelik P, Köksal D, Ulubaş B, Sercan E, Özbudak Ö, Göksel T, Önalan T, Yamansavci E, Türk F, Yuncu G, Çopuraslan Ç, Mardal T, Tuncay E, Karamustafaoğlu A, Yildiz P, Seçik F, Kaplan M, Çağlar E, Ortaköylü M, Önal M, Turna A, Hekimoğlu E, Dalar L, Altin S, Gülhan M, Akpinar E, Savas İ, Firat N, Çamsari G, Özkan G, Çetinkaya E, Kamiloğlu E, Çelik B, Havlucu Y (2015) Patient and physician delay in the diagnosis and treatment of non-small cell lung cancer in Turkey. Cancer Epidemiol 39:216–221
3. Chan BA, Hughes BG (2015) Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. Transl Lung Cancer Res. 4:36–54
4. Gridelli C (2001) The ELVIS trial: a phase III study of single agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian study. Oncologist 6:4–7
5. Des Guetz G, Uzzan B, Nicolas P, Valevre D, Sebbane G, Morere JF (2012) Comparison of the efficacy and safety of single agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis. Crit Rev Oncol Hematol 84:340–349
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献